Methods This study was approved by the International Review Board at Nova Southeastern University in Fort Lauderdale, FL, USA, with clinicaltrials.gov trial identifier number NCT01366859
Carrillo-Norte JA, Garcia-Mir B, Qunitana L, Buracchio B, Guerrero-Bonmatty R
IGF Binding Proteins and Bioavailability The mechanism underlying this enhanced potency relates to IGF-1's complex regulatory system involving IGF binding proteins (IGFBPs), a family of six high-affinity binding proteins (IGFBP-1 through IGFBP-6) that normally sequester the vast majority of circulating IGF-1 and regulate its bioavailability, half-life, and access to cell surface IGF-1 receptors
Gently swirl/roll until fully dissolved (clear solution)
Anti-doping status based on the WADA 2026 Prohibited List